Atezolizumab,Cabozantinib
Exelixis,roche
[]
fantastic presentation by our mentor on the cosmic study #asco22 encouraging clinical activity with manageable toxicity 
#PsyOnc @CettroOncologia | Former Postdoc Fellow & Visiting Scholar @cityofhope | @IPOSPsychoOncol BOD 2021-2023 | #ASCO22 FCOI: https://t.co/wuOhYiJHBM